New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial designed to help understand ...
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial designed to help understand ...
A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal ...
Researchers are recruiting healthy volunteers for a Phase I clinical trial (PlaVac) to test a new candidate vaccine against plague, ...
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that ...
In a carefully controlled clinical trial, Michigan Medicine researchers will examine whether participants who are highly allergic or have a ...
A team of MUSC Children's Health pediatricians was the first in the nation to enroll patients with multisystem inflammatory syndrome ...
Rigel Pharmaceuticals, Inc. announced on Jan. 29 it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program ...
When the efficacy of the Oxford/AstraZeneca vaccine was announced in late 2020, there was some confusion. The overall efficacy of ...
The Department of Defense (DOD) awarded a $6 million agreement to Pulmotect, Inc., a clinical-stage biotechnology company, to execute two ...
Thirteen African countries and an international network of research institutions have joined forces to launch the largest COVID-19 clinical trial ...
The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19 – and ...
Altimmune Inc. has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to commence a Phase ...
There are now two COVID-19 vaccines that, at least according to preliminary reports, appear to be 94.5% and 95% effective. ...
The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ...
U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers University of Minnesota Medical School physician ...
New contract awards by the Biomedical Advanced Research and Development Authority (BARDA) will support three integrated components of the Medical ...
In the earliest days of the pandemic, many immunologists, including me, assumed that patients who produced high quantities of antibodies ...
In a new study, researchers from the Dangerous Pathogens Team at CSIRO conclude vaccines currently under development for COVID-19 should ...
The National Institutes of Health (NIH) today announced it is expanding enrollment in two existing clinical trials to further evaluate ...
Readily available drugs, which dampen the runaway inflammatory response in patients severely ill with COVID-19, save lives, according to evidence ...